Facebook
Twitter
Telegram
Report an ErrorCymaBay Therapeutics Financial Statements 2011-2024 | CBAY
Annual Financial Statements CymaBay Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.43 B | 851 M | 212 M | 369 M | 111 M | 502 M | 419 M | 43.1 M | 20.6 M | 120 M | - | - | - |
Shares |
106 M | 87.8 M | 71.1 M | 68.9 M | 67 M | 57.8 M | 34.9 M | 23.4 M | 18.9 M | 12 M | - | - | - |
Historical Prices |
32.3 | 9.69 | 2.98 | 5.35 | 1.54 | 8.7 | 11.9 | 1.86 | 1.09 | 10 | - | - | - |
Net Income |
-105 M | -106 M | -90 M | -51 M | -103 M | -72.5 M | -27.6 M | -26.7 M | -15.5 M | -31.9 M | -10.1 M | -11.3 M | - |
Revenue |
31.1 M | 1 B | - | - | - | - | 10 M | - | - | - | - | 3.05 M | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-102 M | -93.1 M | -87.6 M | -52.6 M | -108 M | -72.5 M | -21.3 M | -25.6 M | -25.9 M | -24 M | -9.4 M | -10.4 M | - |
Interest Expense |
18.9 M | 14.9 M | 2.58 M | - | - | 336 K | 1.08 M | 1.34 M | 913 K | 755 K | 822 K | 841 K | - |
EBITDA |
-101 M | -92.5 M | -86.9 M | -53.4 M | -103 M | -72.4 M | -21.3 M | -25.6 M | -25.9 M | -24 M | -9.34 M | -10.3 M | - |
Operating Expenses |
133 M | 93.1 M | 87.6 M | 53.3 M | 103 M | 72.5 M | 31.3 M | 25.6 M | 25.9 M | 24 M | 9.4 M | 13.5 M | - |
General and Administrative Expenses |
52 M | 25.1 M | 23 M | 17.4 M | 19.2 M | 14.4 M | 12.4 M | 9.64 M | 8.87 M | 8.18 M | 4.87 M | 4.21 M | - |
All numbers in USD currency
Quarterly Income Statement CymaBay Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
106 M | 102 M | 98 M | 84.7 M | 87.8 M | 87.8 M | 87.8 M | 84.7 M | 69 M | 69 M | 68.9 M | 68.9 M | 68.9 M | 68.9 M | 68.9 M | 68.9 M | 68.7 M | 68.7 M | 61.9 M | 59.5 M | 59.1 M | 58.8 M | 53.8 M | 44.4 M | 40 M | 28.8 M | 26.6 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 21.7 M | 15.3 M | 15.1 M | 14.7 M | 13.5 M | 10.1 M | 9.87 M | 9.46 M | 101 K | 5.85 K | 9.46 M | 5.79 K | 5.79 K | - | - | - | - | - | - |
Net Income |
-33.9 M | -808 K | -28.8 M | - | -24.5 M | -27.1 M | -27.8 M | - | -22.7 M | -23.2 M | -17.6 M | - | -11.4 M | -10.7 M | -13.1 M | - | -26.3 M | -24 M | -23.1 M | -19.4 M | -18.6 M | -17.5 M | -17 M | -5.04 M | -8.23 M | -8.93 M | -5.35 M | - | -5.88 M | -6.99 M | -6.85 M | - | -5.86 M | -1.36 M | -2.33 M | - | -5.96 M | -3.17 M | -10.1 M | - | -1.31 M | -2.22 M | -2.63 M | - | -511 K | - | - | - | - | - | - |
Revenue |
- | 31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.21 M | 4.79 M | 4.79 M | 4.79 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-32.2 M | -99 K | -26.9 M | - | -21.4 M | -23.8 M | -24.5 M | - | -22.2 M | -23.3 M | -17.6 M | - | -11.6 M | -11.2 M | -13.9 M | - | -27.7 M | -25.6 M | -24.3 M | - | -21.1 M | -18 M | -12.8 M | - | -6.39 M | -7.63 M | -2.95 M | - | -5.66 M | -6.35 M | -6.89 M | - | -6.73 M | -6.54 M | -6.78 M | - | -5.54 M | -5.75 M | -5.12 M | - | -1.39 M | -2.14 M | -2.42 M | - | -294 K | - | - | - | - | - | - |
Interest Expense |
4.84 M | 4.62 M | 4.4 M | - | 3.82 M | 3.65 M | 3.36 M | - | 522 K | - | - | - | - | - | - | - | - | - | - | - | 336 K | 128 K | 208 K | - | 258 K | 283 K | 305 K | - | 341 K | 336 K | 332 K | - | 265 K | 165 K | 154 K | - | 191 K | 189 K | 184 K | - | 219 K | 209 K | 212 K | - | 220 K | - | - | - | - | - | - |
EBITDA |
- | - | -26.7 M | - | -20.8 M | -23.4 M | -24.3 M | - | -21.7 M | -22.9 M | -17.5 M | - | -11.2 M | -10.8 M | -13.8 M | - | -27.3 M | -25.4 M | -24.1 M | - | -21.1 M | -17.9 M | -12.8 M | - | -6.37 M | -7.61 M | -2.94 M | - | -5.64 M | -6.34 M | -6.88 M | - | -6.71 M | -6.53 M | -6.77 M | - | -5.52 M | -5.74 M | -5.11 M | - | -1.34 M | -2.1 M | -2.39 M | - | -203 K | - | - | - | - | - | - |
Operating Expenses |
32.2 M | 31.1 M | 26.9 M | - | 21.4 M | 23.8 M | 24.5 M | - | 22.2 M | 23.3 M | 17.6 M | - | 11.6 M | 11.2 M | 13.9 M | - | 27.7 M | 25.6 M | 24.3 M | 20.6 M | 21.1 M | 18 M | 12.8 M | 9.56 M | 6.39 M | 7.63 M | 7.74 M | - | 5.66 M | 6.35 M | 6.89 M | - | 6.73 M | 6.54 M | 6.78 M | - | 5.54 M | 5.75 M | 5.12 M | - | 1.39 M | 2.14 M | 2.42 M | - | 3.21 M | - | - | - | - | - | - |
General and Administrative Expenses |
12.2 M | 11.6 M | 8.32 M | - | 5.9 M | 5.88 M | 6.09 M | - | 5.18 M | 6.52 M | 5.24 M | - | 3.91 M | 3.21 M | 4.42 M | - | 4.51 M | 4.53 M | 5.66 M | - | 3.28 M | 3.57 M | 3.37 M | - | 2.21 M | 3.58 M | 3.7 M | - | 2.13 M | 2.22 M | 2.46 M | - | 2.2 M | 2.28 M | 2.59 M | - | 1.69 M | 1.67 M | 2.5 M | - | 683 K | 1.17 M | 925 K | - | 925 K | - | - | - | - | - | - |
All numbers in USD currency